{"id":13349,"date":"2024-08-23T01:03:03","date_gmt":"2024-08-22T23:03:03","guid":{"rendered":"https:\/\/valintermed.com\/?p=13349"},"modified":"2024-08-23T01:03:03","modified_gmt":"2024-08-22T23:03:03","slug":"makroglobulinemiya-valdenstrema","status":"publish","type":"post","link":"https:\/\/valintermed.com\/en\/medlibrary\/macroglobulinemiya-valdenstrema\/","title":{"rendered":"Waldenstrom's macroglobulinemia"},"content":{"rendered":"
<\/div>\n

Waldenstrom's macroglobulinemia (WMM) is a rare disease of the lymphatic system, which is a non-Hodgkin's lymphoma characterized by an increase in the level of IgM in the blood due to the proliferation of monoclonal B-lymphocytes. This disease is often accompanied by hyperviscosity of the blood, which in turn can lead to impaired microcirculation and other complications. WMM can manifest itself with various symptoms, such as malaise, anemia, thrombocytopenia, skin manifestations, etc. The pathology is chronic and requires careful monitoring and a modern approach to treatment, which is discussed below.<\/p>\n

\n
\n

Content<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n